Compare Unichem Lab with IPCA Labs - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs IPCA LABS - Comparison Results

IPCA LABS 
   Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB IPCA LABS UNICHEM LAB/
IPCA LABS
 
P/E (TTM) x -46.6 23.2 - View Chart
P/BV x 1.1 8.3 13.8% View Chart
Dividend Yield % 1.2 0.1 830.1%  

Financials

 UNICHEM LAB   IPCA LABS
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
IPCA LABS
Mar-19
UNICHEM LAB/
IPCA LABS
5-Yr Chart
Click to enlarge
High Rs2921,042 28.0%   
Low Rs182590 30.8%   
Sales per share (Unadj.) Rs167.7298.6 56.1%  
Earnings per share (Unadj.) Rs-3.635.0 -10.4%  
Cash flow per share (Unadj.) Rs5.949.4 12.0%  
Dividends per share (Unadj.) Rs4.003.00 133.3%  
Dividend yield (eoy) %1.70.4 459.1%  
Book value per share (Unadj.) Rs372.3247.1 150.6%  
Shares outstanding (eoy) m70.38126.35 55.7%   
Bonus/Rights/Conversions ESOPESOS-  
Price / Sales ratio x1.42.7 51.7%   
Avg P/E ratio x-65.323.3 -280.0%  
P/CF ratio (eoy) x39.916.5 241.6%  
Price / Book Value ratio x0.63.3 19.3%  
Dividend payout %-110.28.6 -1,285.3%   
Avg Mkt Cap Rs m16,680103,108 16.2%   
No. of employees `0002.613.4 19.4%   
Total wages/salary Rs m2,3937,874 30.4%   
Avg. sales/employee Rs Th4,535.22,807.0 161.6%   
Avg. wages/employee Rs Th919.8585.8 157.0%   
Avg. net profit/employee Rs Th-98.2329.0 -29.9%   
INCOME DATA
Net Sales Rs m11,80137,732 31.3%  
Other income Rs m984577 170.6%   
Total revenues Rs m12,78538,309 33.4%   
Gross profit Rs m-8356,901 -12.1%  
Depreciation Rs m6741,824 36.9%   
Interest Rs m75189 39.9%   
Profit before tax Rs m-6005,465 -11.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-3431,042 -32.9%   
Profit after tax Rs m-2564,422 -5.8%  
Gross profit margin %-7.118.3 -38.7%  
Effective tax rate %57.319.1 300.2%   
Net profit margin %-2.211.7 -18.5%  
BALANCE SHEET DATA
Current assets Rs m20,38423,778 85.7%   
Current liabilities Rs m5,02910,975 45.8%   
Net working cap to sales %130.133.9 383.5%  
Current ratio x4.12.2 187.1%  
Inventory Days Days105104 101.0%  
Debtors Days Days13566 204.6%  
Net fixed assets Rs m9,02320,368 44.3%   
Share capital Rs m141253 55.7%   
"Free" reserves Rs m26,05830,971 84.1%   
Net worth Rs m26,19931,224 83.9%   
Long term debt Rs m01,409 0.0%   
Total assets Rs m31,49645,507 69.2%  
Interest coverage x-7.030.0 -23.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.40.8 45.2%   
Return on assets %-0.610.1 -5.7%  
Return on equity %-1.014.2 -6.9%  
Return on capital %-2.017.3 -11.5%  
Exports to sales %69.445.9 151.3%   
Imports to sales %016.6 0.0%   
Exports (fob) Rs m8,18817,308 47.3%   
Imports (cif) Rs mNA6,266 0.0%   
Fx inflow Rs m8,18817,308 47.3%   
Fx outflow Rs m5966,266 9.5%   
Net fx Rs m7,59211,042 68.8%   
CASH FLOW
From Operations Rs m-3,2784,923 -66.6%  
From Investments Rs m-2,860-1,563 183.0%  
From Financial Activity Rs m-24-1,832 1.3%  
Net Cashflow Rs m-4,6901,528 -307.0%  

Share Holding

Indian Promoters % 50.1 45.9 109.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 11.4 132.5%  
FIIs % 3.0 25.3 11.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 17.4 182.2%  
Shareholders   20,176 36,892 54.7%  
Pledged promoter(s) holding % 0.0 2.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   FDC  FULFORD INDIA  DR. REDDYS LAB  AJANTA PHARMA  ALEMBIC  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 257 Points Higher; Tata Steel & Hindalco Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (3QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (2QFY20); Net Profit Up 63.7% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 63.7% YoY). Sales on the other hand came in at Rs 12 bn (up 21.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY20); Net Profit Up 101.5% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, IPCA LABS has posted a net profit of Rs 1 bn (up 101.5% YoY). Sales on the other hand came in at Rs 10 bn (up 18.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

This Fund Manager Has Taken the World by Storm. Will You Invest With Her?(Profit Hunter)

Apr 26, 2021

Should you invest with this Rockstar fund manager who has outperformed in a big way?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


May 7, 2021 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS